Merck & Co., Inc. MRK on NYSE
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0000310158
0000310158
EIN:
22-1918501
22-1918501
LEI:
(CF Office: 03 Life Sciences)
Business address:
2000 GALLOPING HILL ROAD, KENILWORTH, NJ, 07033
Phone: 908-740-4000
2000 GALLOPING HILL ROAD, KENILWORTH, NJ, 07033
Phone: 908-740-4000
Mailing address:
2000 GALLOPING HILL ROAD, KENILWORTH, NJ, 07033
2000 GALLOPING HILL ROAD, KENILWORTH, NJ, 07033
Category:
Large accelerated filer
Large accelerated filer
Former names:
- Merck & Co. Inc. - filings through 2014-12-09
- SCHERING PLOUGH CORP - filings through 2009-10-29
Filings:
2,815 EDGAR filings since March 7, 1994
2,815 EDGAR filings since March 7, 1994
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 6, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 25, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- February 19, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - 13F-HR: Quarterly report filed by institutional managers, Holdings Open documentClick to Open document FilingOpen filingClick to Open filing
- February 13, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- February 4, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 25, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 6, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 5, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 3, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- April 11, 2024 - 10-K/A: Annual report for year ending December 31, 2023 - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 11, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- February 20, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 13, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 11, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- March 6, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 3, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- December 23, 2024 - SCHEDULE 13G: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 1,002 entries
Data source:
CIK0000310158.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
